Company Description
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.
The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups.
In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products.
It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau.
USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
| Country | United States |
| Founded | 1992 |
| IPO Date | Jul 25, 1996 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 1,800 |
| CEO | Jim Brown |
Contact Details
Address: 3838 West Parkway Boulevard Salt Lake City, Utah 84120 United States | |
| Phone | 801 954 7100 |
| Website | usana.com |
Stock Details
| Ticker Symbol | USNA |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000896264 |
| CUSIP Number | 90328M107 |
| ISIN Number | US90328M1071 |
| Employer ID | 87-0500306 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Jim Brown | Chief Executive Officer and President |
| Kevin G. Guest | Executive Chairman |
| G. Douglas Hekking | Chief Financial Officer |
| Walter Noot | Chief Operating Officer |
| Daniel A. Macuga Jr. | Chief Communications and Marketing Officer |
| Dr. Myron W. Wentz Ph.D. | Founder and Chairman Emeritus |
| Dr. John Cuomo | Executive Director of Product Development and Technology |
| Dr. Robert A. Sinnott M.N.S., Ph.D. | Chief Scientific Officer |
| Peter Benedict | Chief Information Officer |
| Patrique Richards | Executive Director of Investor Relations and Business Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 5, 2024 | 10-Q | Quarterly Report |
| Oct 22, 2024 | 8-K | Current Report |
| Oct 21, 2024 | SCHEDULE 13G | Filing |
| Aug 13, 2024 | 144 | Filing |
| Aug 6, 2024 | 10-Q | Quarterly Report |
| Jul 31, 2024 | 144 | Filing |
| Jul 23, 2024 | 8-K | Current Report |
| Jun 20, 2024 | 11-K | Annual report of employee stock purchase, savings and similar plans |
| Jun 7, 2024 | 144 | Filing |
| May 22, 2024 | 144 | Filing |